• 1995

Company Description

Viventia Bio Inc. is a privately held biopharmaceutical company specializing in the discovery and development of a new generation

Viventia Bio is the leader in developing next generation oncology therapeutics utilizing our proprietary Targeted Protein Therapeutic technology (TPT). We believe our TPT based product candidates enjoy significant advantages in treating cancer versus earlier technologies.